, Volume 36, Issue 2, pp 187-189
Date: 13 Jan 2010

The Surviving Sepsis Campaign: robust evaluation and high-quality primary research is still needed

This is an excerpt from the content

The initial aims of the Surviving Sepsis Campaign, which arose from the Declaration of Barcelona in October 2002, were to raise public and professional awareness of severe sepsis and its treatment, the development of practice guidelines and “worldwide standards of care…through the development of global protocols”. These latter aims led to a partnership with the Institute of Healthcare Improvement, which established treatment bundles described as “a group of interventions that, when executed together, result in better outcomes than when implemented individually’.

The first iteration of the guidelines arising from the campaign was published in 2004, with a second in 2008. Whilst generally welcomed, pharmaceutical company funding and promotion led to robust criticism in some quarters, which was equally robustly rebutted [13].

Regardless of the controversy surrounding the funding and promotion of the campaign, the campaign continues, and the true test should be whether it has improved the t

This article is being simultaneously published in Intensive Care Medicine and Critical Care Medicine.
This editorial refers to the article available at: doi:10.1007/s00134-009-1738-3.